Secondary aims were to describe the distribution and associations of cystatin C, and to explore the impact of adding targeted cystatin C measurement to SCr eGFR and urine albumin to creatinine ratio (uACR) measurements on the diagnosis and risk assessment of CKD. The gene discussed is ALB; the disease is chronic kidney disease.